The Efficacy and Safety of Erbium‐Doped Yttrium Aluminum Garnet Laser Therapy for Stress Urinary Incontinence: A Systematic Review and Meta‐Analysis DOI
Huilei Yan, Jialei Wang,

Yefei Ding

et al.

Lasers in Surgery and Medicine, Journal Year: 2025, Volume and Issue: unknown

Published: April 6, 2025

ABSTRACT Objectives The erbium‐doped yttrium aluminum garnet(Er:YAG) laser therapy has recently emerged as a novel treatment for stress urinary incontinence (SUI) in women. purpose of this meta‐analysis was to evaluate the efficacy and safety Er:YAG management SUI. Materials Methods We conducted search databases MEDLINE, EMBASE, Cochrane Library, up December 2024, identify randomized controlled trials (RCTs) that mentioned use A systematic review conducted. Results included four publications with total 390 patients diagnosed Posttreatment analysis revealed statistically significant improvements group 1‐h pad test (mean difference [MD]: −10.42; 95% confidence interval [CI], −17.32 −3.53; p = 0.003) number subjective cures assessed by International Consultation on Incontinence Questionnaire‐Short Form (ICIQ‐SF) (odds ratio [OR]; 6.21, CI; 1.55–24.84, 0.01). However, no differences were observed change ICIQ‐SF scores (MD: −0.15; CI, −0.77 1.07; 0.75) Pelvic Organ Prolapse/Urinary Sexual Questionnaire (PISQ‐12) 0.81; −0.24 1.85; 0.13). In terms comfort, pain visual analog score (VAS) higher versus sham following both sessions (The VAS after session one (MD; 3.72, 3.24–419, < 0.00001). two(MD; 2.64, 2.12–3.15, Regarding adverse events, there between increased vaginal discharge (OR; 4.64, 0.27–78.30, 0.29), discomfort 1.31, 0.62–2.73, 0.48), suspected tract infection (UTI) 3.44, 0.57–20.58, 0.18). Conclusions Our indicates appears be safe effective option

Language: Английский

Exploring the role of laser therapy for stress urinary incontinence: a literature review DOI

Pei-Chen Li,

Dah‐Ching Ding

Lasers in Medical Science, Journal Year: 2025, Volume and Issue: 40(1)

Published: March 5, 2025

Language: Английский

Citations

0
The Efficacy and Safety of Erbium‐Doped Yttrium Aluminum Garnet Laser Therapy for Stress Urinary Incontinence: A Systematic Review and Meta‐Analysis DOI
Huilei Yan, Jialei Wang,

Yefei Ding

et al.

Lasers in Surgery and Medicine, Journal Year: 2025, Volume and Issue: unknown

Published: April 6, 2025

ABSTRACT Objectives The erbium‐doped yttrium aluminum garnet(Er:YAG) laser therapy has recently emerged as a novel treatment for stress urinary incontinence (SUI) in women. purpose of this meta‐analysis was to evaluate the efficacy and safety Er:YAG management SUI. Materials Methods We conducted search databases MEDLINE, EMBASE, Cochrane Library, up December 2024, identify randomized controlled trials (RCTs) that mentioned use A systematic review conducted. Results included four publications with total 390 patients diagnosed Posttreatment analysis revealed statistically significant improvements group 1‐h pad test (mean difference [MD]: −10.42; 95% confidence interval [CI], −17.32 −3.53; p = 0.003) number subjective cures assessed by International Consultation on Incontinence Questionnaire‐Short Form (ICIQ‐SF) (odds ratio [OR]; 6.21, CI; 1.55–24.84, 0.01). However, no differences were observed change ICIQ‐SF scores (MD: −0.15; CI, −0.77 1.07; 0.75) Pelvic Organ Prolapse/Urinary Sexual Questionnaire (PISQ‐12) 0.81; −0.24 1.85; 0.13). In terms comfort, pain visual analog score (VAS) higher versus sham following both sessions (The VAS after session one (MD; 3.72, 3.24–419, < 0.00001). two(MD; 2.64, 2.12–3.15, Regarding adverse events, there between increased vaginal discharge (OR; 4.64, 0.27–78.30, 0.29), discomfort 1.31, 0.62–2.73, 0.48), suspected tract infection (UTI) 3.44, 0.57–20.58, 0.18). Conclusions Our indicates appears be safe effective option

Language: Английский

Citations

0